|
ALXO ALX Oncology Holdings Inc 1810182 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-17,971,000.00 |
| Balance Sheet |
|
Current Assets
|
$143,457,000.00 |
|
Assets
|
$160,820,000.00 |
|
Current Liabilities
|
$14,776,000.00 |
|
Liabilities
|
$24,633,000.00 |
|
Equity
|
$136,187,000.00 |
|
Shares Out
|
138216247.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-34,705,000.00 |
|
Investing Cash Flow
|
$-98,513,000.00 |
| Market Analysis |
Market Cap
|
$275,050,331.53 |
|
Price
|
$1.99 |
|
BVPS
|
0.99 |
|
PB
|
2.01 |
|
EPS
|
-0.13 |
|
FCF
|
$-34,772,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:38 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-27 |
-0.42 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-08 |
-0.17 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.49 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-07 |
-0.41 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ALXO documents filed with the SEC.
ALXO Filings
Clear
